MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Section: Otorhinolaryngology
Otorhinolaryngology

Reinke’s Edema Treatment Revolutionized: Comparing Office-Based 445-nm Blue Laser to Traditional Microlaryngoscopy

MedXY Editorial TeamNov 19, 2026
blue laser therapyoffice-based treatmentmicrolaryngoscopyVoice quality

Highlight

This article examines recent clinical findings comparing office-based 445-nm blue laser treatment to microlaryngoscopy under general anesthesia for Reinke’s edema. Key highlights include: substantial voice-related quality of life improvements post-treatment; high rates of complete edema regression with both methods; significantly shorter operative times for office-based treatments; and excellent safety profiles with no adverse events reported.

Study Background

Reinke’s edema is a benign swelling of the vocal fold lamina propria resulting from fluid accumulation, commonly linked to smoking and voice misuse. The condition causes hoarseness and voice changes, significantly impacting patients’ quality of life, particularly those reliant on vocal performance professionally. Traditional treatment often involves microlaryngoscopy under general anesthesia (GA) for surgical removal or reduction of the edema. However, general anesthesia presents inherent risks and resource demands. Innovations in office-based procedures using specialized lasers present an opportunity for less invasive management with potential benefits including reduced operative time, quicker recovery, and lower healthcare costs. The 445-nm blue laser, owing to its precise tissue interaction and hemostatic properties, has emerged as a promising alternative approach.

Study Design

This prospective observational study was conducted at a tertiary laryngological center from 2018 to 2025 and included 103 adult patients diagnosed with Reinke’s edema suitable for surgical intervention. Sixty-three patients underwent office-based laser (OBL) treatment using a 445-nm blue laser, while 40 patients underwent conventional microlaryngoscopy under general anesthesia. Primary endpoints included voice-related quality of life measured by the Voice Handicap Index-10 (VHI-10) and endoscopic grading of edema before and after treatment. Secondary outcomes comprised operative time and safety profile assessment. Statistical analyses involved paired t-tests and Wilcoxon signed rank tests for within-group comparisons, and Welch t-tests for between-group comparisons.

Key Findings

Voice-Related Quality of Life Improvements: The OBL group experienced marked improvement in VHI-10 scores, decreasing from 15.0 ± 8.8 pre-treatment to 2.0 ± 3.5 post-treatment (p < 0.001). Similarly, the GA group showed significant improvement from 19.5 ± 10.7 to 5.1 ± 6.7 (p < 0.001). These data indicate that both treatment modalities substantially alleviate voice handicap, with the office-based approach demonstrating numerically greater absolute improvement.

Complete Edema Regression: Post-treatment endoscopic evaluation revealed complete regression of edema (grade 0) in 82.7% (43/52) of patients treated with the 445-nm blue laser and 80.0% (16/20) in the GA group, reflecting comparable efficacy in anatomical outcomes.

Operative Time: The mean procedure duration with office-based laser therapy was 6.9 ± 3.1 minutes, significantly shorter than the 37.0 ± 17.1 minutes required for microlaryngoscopy under GA (p < 0.001), highlighting a substantive efficiency advantage.

Safety and Retreatment: No adverse events were reported in either group. Eleven patients (21.2%) in the OBL cohort required retreatment, with up to three sessions, suggesting repeat office-based laser treatment is feasible and well tolerated.

Expert Commentary

The transition of Reinke’s edema management from an operating room environment requiring general anesthesia to an office-based procedure utilizing 445-nm blue laser technology signifies a paradigm shift. The precision and hemostatic properties of the blue laser facilitate effective edema vaporization or resection with minimal tissue damage and patient discomfort. While the GA approach remains a standard, especially for extensive disease, the office-based method offers considerable advantages in patient convenience, cost reduction, and safety profile.

Limitations include the potential need for multiple treatment sessions in office-based therapy and the absence of randomized controlled trials comparing these interventions directly. Additionally, long-term voice outcomes and durability beyond the study period warrant further investigation. Selection criteria are crucial to identify patients who would most benefit from the minimally invasive route without compromising clinical effectiveness.

Conclusion

The study demonstrates that office-based 445-nm blue laser treatment is a highly efficacious and safe alternative for managing Reinke’s edema, offering significant improvements in voice-related quality of life and endoscopic outcomes with substantially reduced operative time. This modality represents a patient-friendly, resource-efficient option that may redefine standard care in appropriately selected cases. Ongoing research should focus on refining patient selection, optimizing treatment protocols, and evaluating long-term benefits to fully integrate office-based laser therapy into routine laryngological practice.

Funding and Clinical Trials

The original study did not specify funding sources, and there is no current information about registered clinical trials linked to this comparison.

References

  • Mora F, Filauro M, Frascio M, Moro C, Ajasllari G, Peretti G. Reinke’s Edema: From the Operating Theater to Office-Based Blue Laser Treatment. The Laryngoscope. 2026 Nov 10. PMID: 43006750.

  • Remacle M, Lawson G, Jamart J. Treatment of Reinke’s edema using office-based laser therapy: A systematic review. Eur Arch Otorhinolaryngol. 2022;279(5):2155-2162.

  • Spielmann PM, Blitzer A. Voice rehabilitation following Reinke’s edema excision. Otolaryngol Clin North Am. 2011;44(5):1167-1180.

  • Wackers FJ, Claeys S, Lebacq J, Remacle M. Office-based laser therapy of Reinke’s edema: Clinical outcomes and voice quality improvement. Eur Arch Otorhinolaryngol. 2019;276(8):2177-2185.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Comparative Outcomes of External versus Powered Endoscopic Dacryocystorhinostomy with Mitomycin C in Nasolacrimal Duct Obstruction: A Randomized Controlled Trial

OtorhinolaryngologyNov 21, 2026

Philtrum Fasciocutaneous Advancement Flap: A Reliable Single-Stage Solution for Columellar Reconstruction in Revision Rhinoseptoplasty

OtorhinolaryngologyNov 18, 2026

Efficacy of Intratympanic Sodium Thiosulfate Gel Injection to Prevent Cisplatin-Induced Ototoxicity: A Comprehensive Clinical Review

OtorhinolaryngologyNov 17, 2026
Loading comments...

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story